查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1212528

生物科技試劑的全球市場 2023

Biotechnology Reagents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 232 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物科技試劑的全球市場到2030年將達到1,351億美元

在COVID-19後改變的商務環境中，2022年939億美元的生物科技試劑的全球市場到2030年將達到1351億美元的規模，在分析期間2022年～2030年間預計將以4.6％的年複合成長率增長。本報告所分析的市場區隔之一的層析法，年複合成長率將記錄3.7％，到分析期間結束時達到406億美元。考慮疫情後的復甦，體外診斷市場區隔今後8年的年複合成長率將修正為4％。

美國市場估算為是256億美元，中國則將以年複合成長率7.6％成長。

美國的生物科技試劑市場在2022年估算為256億美元。作為世界第2大經濟大國的中國，在2022年～2030年間預計將以年複合成長率7.6％推移，2030年達到284億美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年間預計將各以1.6％和5.1％的速度成長。在歐洲市場中，德國將以年複合成長率2.4％成長。澳洲，印度，韓國等國家推動下亞太地區的市場到2030年將達到之前達到182億美元。

調查對像企業範例

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP-3533

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biotechnology Reagents Market to Reach $135.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biotechnology Reagents estimated at US$93.9 Billion in the year 2022, is projected to reach a revised size of US$135.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Chromatography, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$40.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the In-vitro Diagnostics segment is readjusted to a revised 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $25.6 Billion, While China is Forecast to Grow at 7.6% CAGR

The Biotechnology Reagents market in the U.S. is estimated at US$25.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.4 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$18.2 Billion by the year 2030.

Select Competitors (Total 267 Featured):

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biotechnology Reagents - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biotechnology Reagents Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 4: World 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 7: World 18-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 10: World 18-Year Perspective for In-vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 13: World 18-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 16: World 18-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 19: World 18-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: USA 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: Canada 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • JAPAN
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: Japan 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • CHINA
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: China 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • EUROPE
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Europe 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Europe 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • FRANCE
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: France 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • GERMANY
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Germany 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Italy 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: UK 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Spain 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Russia 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Rest of Europe 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Asia-Pacific 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Asia-Pacific 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Australia 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • INDIA
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: India 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: South Korea 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Biotechnology Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Latin America 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Latin America 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Argentina 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Brazil 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Mexico 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Rest of Latin America 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Biotechnology Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Middle East 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Middle East 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Iran 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Israel 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 109: Saudi Arabia 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 112: UAE 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 115: Rest of Middle East 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
  • AFRICA
    • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 118: Africa 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030

IV. COMPETITION